Department of Clinical Medicine, School of Medicine, University of Sao Paulo, 01246-903 São Paulo, SP, Brazil.
BMC Pulm Med. 2013 Aug 15;13:52. doi: 10.1186/1471-2466-13-52.
The importance of the lung parenchyma in the pathophysiology of asthma has previously been demonstrated. Considering that nitric oxide synthases (NOS) and arginases compete for the same substrate, it is worthwhile to elucidate the effects of complex NOS-arginase dysfunction in the pathophysiology of asthma, particularly, related to distal lung tissue. We evaluated the effects of arginase and iNOS inhibition on distal lung mechanics and oxidative stress pathway activation in a model of chronic pulmonary allergic inflammation in guinea pigs.
Guinea pigs were exposed to repeated ovalbumin inhalations (twice a week for 4 weeks). The animals received 1400 W (an iNOS-specific inhibitor) for 4 days beginning at the last inhalation. Afterwards, the animals were anesthetized and exsanguinated; then, a slice of the distal lung was evaluated by oscillatory mechanics, and an arginase inhibitor (nor-NOHA) or vehicle was infused in a Krebs solution bath. Tissue resistance (Rt) and elastance (Et) were assessed before and after ovalbumin challenge (0.1%), and lung strips were submitted to histopathological studies.
Ovalbumin-exposed animals presented an increase in the maximal Rt and Et responses after antigen challenge (p<0.001), in the number of iNOS positive cells (p<0.001) and in the expression of arginase 2, 8-isoprostane and NF-kB (p<0.001) in distal lung tissue. The 1400 W administration reduced all these responses (p<0.001) in alveolar septa. Ovalbumin-exposed animals that received nor-NOHA had a reduction of Rt, Et after antigen challenge, iNOS positive cells and 8-isoprostane and NF-kB (p<0.001) in lung tissue. The activity of arginase 2 was reduced only in the groups treated with nor-NOHA (p <0.05). There was a reduction of 8-isoprostane expression in OVA-NOR-W compared to OVA-NOR (p<0.001).
In this experimental model, increased arginase content and iNOS-positive cells were associated with the constriction of distal lung parenchyma. This functional alteration may be due to a high expression of 8-isoprostane, which had a procontractile effect. The mechanism involved in this response is likely related to the modulation of NF-kB expression, which contributed to the activation of the arginase and iNOS pathways. The association of both inhibitors potentiated the reduction of 8-isoprostane expression in this animal model.
先前已经证明,肺实质在哮喘的病理生理学中具有重要意义。考虑到一氧化氮合酶(NOS)和精氨酸酶竞争相同的底物,阐明哮喘病理生理学中复杂的 NOS-精氨酸酶功能障碍的影响是值得的,特别是与远端肺组织相关。我们评估了精氨酸酶和 iNOS 抑制对豚鼠慢性肺变应性炎症模型中远端肺力学和氧化应激途径激活的影响。
豚鼠反复接受卵清蛋白吸入(每周两次,共 4 周)。动物在最后一次吸入后第 4 天开始接受 1400W(一种 iNOS 特异性抑制剂)治疗 4 天。之后,对动物进行麻醉和放血;然后,通过振荡力学评估远端肺切片,并在 Krebs 溶液浴中输注精氨酸酶抑制剂(nor-NOHA)或载体。在卵清蛋白(0.1%)挑战之前和之后评估组织阻力(Rt)和弹性(Et),并对肺条进行组织学研究。
卵清蛋白暴露的动物在抗原挑战后表现出最大 Rt 和 Et 反应增加(p<0.001),iNOS 阳性细胞数量增加(p<0.001),以及远端肺组织中精氨酸酶 2、8-异前列腺素和 NF-kB 的表达增加(p<0.001)。1400W 给药减少了肺泡隔中的所有这些反应(p<0.001)。接受 nor-NOHA 的卵清蛋白暴露动物在抗原挑战后 Rt、Et、iNOS 阳性细胞和肺组织中的 8-异前列腺素和 NF-kB 减少(p<0.001)。只有 nor-NOHA 治疗组的精氨酸酶 2 活性降低(p<0.05)。与 OVA-NOR 相比,OVA-NOR-W 组的 8-异前列腺素表达减少(p<0.001)。
在这个实验模型中,精氨酸酶含量和 iNOS 阳性细胞的增加与远端肺实质的收缩有关。这种功能改变可能是由于 8-异前列腺素的高表达产生了促收缩作用。这种反应涉及的机制可能与 NF-kB 表达的调节有关,这有助于激活精氨酸酶和 iNOS 途径。两种抑制剂的联合使用增强了该动物模型中 8-异前列腺素表达的减少。